EA200201083A1 - Противоопухолевые производные эктейнасцидина - Google Patents
Противоопухолевые производные эктейнасцидинаInfo
- Publication number
- EA200201083A1 EA200201083A1 EA200201083A EA200201083A EA200201083A1 EA 200201083 A1 EA200201083 A1 EA 200201083A1 EA 200201083 A EA200201083 A EA 200201083A EA 200201083 A EA200201083 A EA 200201083A EA 200201083 A1 EA200201083 A1 EA 200201083A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ekteynascidine
- derivatives
- bridge
- compounds
- tumor derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Раскрыты соединения, обладающие, конденсированной системой эктейнасцидина из пяти колец с 1,4-мостиком, имеющим структуру формулы (VIa или VIb), а также их производные по -NHили -ОН группе 1,4-мостика. Такие соединения пригодны для лечения опухолей.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0009043A GB0009043D0 (en) | 2000-04-12 | 2000-04-12 | New autitumoural derivatives of ET-743 |
PCT/GB2000/001852 WO2000069862A2 (en) | 1999-05-14 | 2000-05-15 | Hemisynthetic method and intermediates thereof |
GB0022644A GB0022644D0 (en) | 2000-09-14 | 2000-09-14 | Antitumoral derivatives of ET-743 |
PCT/GB2001/001667 WO2001077115A1 (en) | 2000-04-12 | 2001-04-12 | Antitumoral ecteinascidin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200201083A1 true EA200201083A1 (ru) | 2003-04-24 |
EA006206B1 EA006206B1 (ru) | 2005-10-27 |
Family
ID=26244092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200201083A EA006206B1 (ru) | 2000-04-12 | 2001-04-12 | Противоопухолевые производные эктейнасцидина |
Country Status (27)
Country | Link |
---|---|
US (1) | US7202361B2 (ru) |
EP (1) | EP1280809B1 (ru) |
JP (1) | JP5219323B2 (ru) |
KR (1) | KR100886496B1 (ru) |
CN (1) | CN1436191B (ru) |
AR (1) | AR032879A1 (ru) |
AT (1) | ATE299146T1 (ru) |
AU (1) | AU784249C (ru) |
BG (1) | BG65987B1 (ru) |
BR (1) | BRPI0110024B8 (ru) |
CA (1) | CA2406080C (ru) |
CZ (1) | CZ304749B6 (ru) |
DE (1) | DE60111845T2 (ru) |
DK (1) | DK1280809T3 (ru) |
EA (1) | EA006206B1 (ru) |
ES (1) | ES2244598T3 (ru) |
HK (1) | HK1049005B (ru) |
HU (1) | HU230918B1 (ru) |
IL (1) | IL152094A (ru) |
MX (1) | MXPA02010088A (ru) |
NO (1) | NO329125B1 (ru) |
NZ (1) | NZ521550A (ru) |
PL (1) | PL210703B1 (ru) |
PT (1) | PT1280809E (ru) |
SI (1) | SI1280809T1 (ru) |
SK (1) | SK288017B6 (ru) |
WO (1) | WO2001077115A1 (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK285069B6 (sk) * | 1998-05-11 | 2006-05-04 | Pharma Mar, S. A. | Zlúčeniny, ktoré sú metabolitmi ekteinascidínu 743, farmaceutické prostriedky s ich obsahom a ich použitie |
MY164077A (en) | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
MY130271A (en) * | 1999-05-14 | 2007-06-29 | Pharma Mar Sa | Hemisynthetic method and new compounds |
US7919493B2 (en) | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
US7420051B2 (en) | 2000-05-15 | 2008-09-02 | Pharma Mar, S.A. | Synthetic process for the manufacture of an ecteinaschidin compound |
MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
GB0117402D0 (en) | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
GB0119243D0 (en) * | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
WO2003039571A1 (en) * | 2001-10-19 | 2003-05-15 | Pharmamar S.A. | Improved use of antitumoral compound in cancer therapy |
JP4208469B2 (ja) * | 2002-01-29 | 2009-01-14 | 独立行政法人科学技術振興機構 | エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法 |
GB0202544D0 (en) * | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
RS50692B (sr) | 2003-11-13 | 2010-06-30 | Pharma Mar S.A.U. | Kombinacija et-743 sa prolekovima 5-fluorouracila za lečenje kancera |
JP2008514688A (ja) * | 2004-09-29 | 2008-05-08 | ファルマ・マル・エス・アー, ソシエダッド・ユニペルソナル | 抗炎症剤としてのエクテイナシジン化合物 |
BRPI0517238B1 (pt) | 2004-10-29 | 2021-11-09 | Pharma Mar, S.A. | Composições que compreendem ecteinascidina e um dissacarídeo, método para produzir um frasco que contém a referida composição e para preparar uma solução para infusão intravenosa e uso da referida solução |
US8067462B2 (en) * | 2004-12-20 | 2011-11-29 | The Trustees Of Columbia University In The City Of New York | Processes of making sesquiterpenoid tashironin, its analogs and their uses |
US20090131498A1 (en) * | 2005-01-18 | 2009-05-21 | Danishefsky Samuel J | Enantioselective Synthesis of Merrilactone and Its Analogs |
GB0522082D0 (en) | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
WO2007087220A2 (en) * | 2006-01-25 | 2007-08-02 | The Trustees Of Columbia University In The City Of New York | The total synthesis of ecteinascidin 743 and derivatives thereof |
FR2936951B1 (fr) * | 2008-10-10 | 2010-12-03 | Novexel | Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments |
CN103038240A (zh) | 2010-05-25 | 2013-04-10 | 法马马有限公司 | 制备海鞘素化合物的合成方法 |
KR20170096065A (ko) | 2010-11-12 | 2017-08-23 | 파르마 마르 에스.에이. | 항종양 알칼로이드를 이용한 병용요법 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
CN112679513B (zh) * | 2019-10-18 | 2023-08-25 | 南通诺泰生物医药技术有限公司 | 一种制备曲贝替定的关键中间体的方法 |
CN114940682A (zh) * | 2022-05-18 | 2022-08-26 | 博瑞制药(苏州)有限公司 | 芦比替定的晶型及其制备方法和用途 |
CN115677728A (zh) * | 2022-11-02 | 2023-02-03 | 成都科岭源医药技术有限公司 | 一种海鞘素类化合物中间体的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59225189A (ja) | 1983-06-03 | 1984-12-18 | Shionogi & Co Ltd | キノナミン誘導体およびその製造法 |
JPS6084288A (ja) | 1983-10-13 | 1985-05-13 | Shionogi & Co Ltd | シアノキノナミンアセテ−ト類およびその製造法 |
US5089273A (en) | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
US5149804A (en) | 1990-11-30 | 1992-09-22 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins 736 and 722 |
EP0309477B1 (en) | 1986-06-09 | 1991-11-06 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759a, 759b and 770 |
US5256663A (en) | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
US5721365A (en) * | 1989-09-15 | 1998-02-24 | Us Health | N-substituted piperazine NONOates |
US5478932A (en) | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
US5721362A (en) | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
US5985876A (en) * | 1997-04-15 | 1999-11-16 | Univ Illinois | Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
SK285069B6 (sk) | 1998-05-11 | 2006-05-04 | Pharma Mar, S. A. | Zlúčeniny, ktoré sú metabolitmi ekteinascidínu 743, farmaceutické prostriedky s ich obsahom a ich použitie |
US6124292A (en) | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
MY130271A (en) | 1999-05-14 | 2007-06-29 | Pharma Mar Sa | Hemisynthetic method and new compounds |
US6686470B2 (en) | 2000-01-19 | 2004-02-03 | The Trustees Of Columbia University In The City Of New York | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
MXPA02011319A (es) | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
-
2001
- 2001-04-12 DK DK01919669T patent/DK1280809T3/da active
- 2001-04-12 CA CA2406080A patent/CA2406080C/en not_active Expired - Lifetime
- 2001-04-12 EP EP01919669A patent/EP1280809B1/en not_active Expired - Lifetime
- 2001-04-12 PL PL357574A patent/PL210703B1/pl unknown
- 2001-04-12 SK SK1435-2002A patent/SK288017B6/sk not_active IP Right Cessation
- 2001-04-12 WO PCT/GB2001/001667 patent/WO2001077115A1/en active IP Right Grant
- 2001-04-12 NZ NZ521550A patent/NZ521550A/en not_active IP Right Cessation
- 2001-04-12 DE DE60111845T patent/DE60111845T2/de not_active Expired - Lifetime
- 2001-04-12 EA EA200201083A patent/EA006206B1/ru not_active IP Right Cessation
- 2001-04-12 AU AU46729/01A patent/AU784249C/en not_active Expired
- 2001-04-12 AT AT01919669T patent/ATE299146T1/de active
- 2001-04-12 HU HU0300534A patent/HU230918B1/hu unknown
- 2001-04-12 BR BRPI0110024-6 patent/BRPI0110024B8/pt not_active IP Right Cessation
- 2001-04-12 ES ES01919669T patent/ES2244598T3/es not_active Expired - Lifetime
- 2001-04-12 MX MXPA02010088A patent/MXPA02010088A/es active IP Right Grant
- 2001-04-12 SI SI200130394T patent/SI1280809T1/sl unknown
- 2001-04-12 KR KR1020027013749A patent/KR100886496B1/ko active IP Right Grant
- 2001-04-12 US US10/240,963 patent/US7202361B2/en not_active Expired - Lifetime
- 2001-04-12 IL IL152094A patent/IL152094A/en active IP Right Grant
- 2001-04-12 CZ CZ2002-3352A patent/CZ304749B6/cs not_active IP Right Cessation
- 2001-04-12 PT PT01919669T patent/PT1280809E/pt unknown
- 2001-04-12 JP JP2001575588A patent/JP5219323B2/ja not_active Expired - Lifetime
- 2001-04-12 CN CN01810939XA patent/CN1436191B/zh not_active Expired - Lifetime
- 2001-04-16 AR ARP010101773A patent/AR032879A1/es active IP Right Grant
-
2002
- 2002-10-11 NO NO20024906A patent/NO329125B1/no not_active IP Right Cessation
- 2002-10-24 BG BG107220A patent/BG65987B1/bg unknown
-
2003
- 2003-02-20 HK HK03101292.0A patent/HK1049005B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200201083A1 (ru) | Противоопухолевые производные эктейнасцидина | |
EA200000592A1 (ru) | Азаполициклические соединения, конденсированные с арилом | |
EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
ES2172864T3 (es) | 2-metoxibenzofenonas fungicidas. | |
ES2103751T3 (es) | Procedimiento para la obtencion de oxetanonas. | |
EA200400893A1 (ru) | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств | |
TR200101969T2 (tr) | Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları. | |
FR2733244B1 (fr) | Systeme de stabilisants a base de derives de polyalkylpiperidine | |
EA200300050A1 (ru) | Гликопептидфосфонатные производные | |
ECSP034600A (es) | Compuestos de lactama | |
CY1105387T1 (el) | Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου | |
EA200100983A1 (ru) | Производные 13-метилэритромицина | |
DE69634961D1 (de) | Neue zyklische depsipeptid pf1022 derivate | |
ES2169242T3 (es) | 2-amino-benzoxazinonas para el tratamiento de infecciones virales. | |
EA199900163A1 (ru) | Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств | |
TR200002932T2 (tr) | Azabisayklik 5HT1 Alıcı liganolları | |
EA199900235A1 (ru) | Аморфные бензотиофены, способы получения и способы применения | |
ES2101798T3 (es) | Policondensados melaminicos. | |
DE69703115T2 (de) | Zwischenprodukte um 2-imidazolin-5onederivate herzustellen. | |
MX9709016A (es) | 2-amino-benzoxazinonas, composiciones que las contienen y uso de las mismas. | |
PT1140932E (pt) | Derivados de 1,8-benzonaftiridina | |
EA200101090A1 (ru) | Псевдомициновые природные продукты | |
EA199800931A1 (ru) | Способ получения ингибиторов фосфодиэстеразы iv | |
DE60108242D1 (de) | Herstellung von hydroxyverbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
MK4A | Patent expired |
Designated state(s): BY RU |